NIH-funded discovery uses common antifungal drug to improve lungs’ ability to fight infection Researchers say a widely-used antifungal drug may hold promise for treating people with cystic fibrosis, a life-threatening genetic disorder that causes serious damage to the lungs. In studies using human cells and animals models, the researchers found...
Clare M. Waterman, Ph.D., NIH distinguished investigator and director of the NHLBI Laboratory of Cell and Tissue Morphodynamics has been elected to the National Academy of Sciences (NAS), the highest honor for American scholars in recognition of their distinguished and continuing achievements in ori
An NHLBI-funded study showed that the addition of a nurse-led intervention for hypertension management to health insurance coverage was more effective in lowering blood pressure than the provision of health insurance alone in Ghana.
Throughout May 2018, National Asthma and Allergy Awareness Month, the NHLBI wishes to recognize Dr. Esteban Burchard and his team on the 20th anniversary of GALA (Genetics of Asthma in Latino Americans), the largest study of asthma in Latino children in the United States.
Researchers say they have developed a synthetic version of a natural protein called lung surfactant that restored breathing capacity to the injured lungs of rats. The artificial substance could lead to better, cheaper treatments for lung injury in humans, they say.
Researchers are reporting in a new study that making five health lifestyle choices might prolong your life by at least 10 years.
Researchers are reporting that common therapy options for psoriasis, a chronic an inflammatory skin disease, can reduce plaque levels in the blood vessels of the heart. In this new observational study, the researchers also found that the psoriasis treatments--including so-called biologic therapies t
The vascular endothelium defines the interface between blood and tissue, forming a semi-permeable barrier that controls the exchange of nutrients.
Some studies have shown that obese individuals have a lower risk of cardiovascular problems when they are metabolically healthy, but accumulating evidence suggests that the risk still remains high in this group.
Extracellular vesicles are small structures that are secreted by cells and contain molecules called microRNAs, which can induce the recovery of damaged heart tissue. However, the therapeutic effects of extracellular vesicles are short-lived.